Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion evidence source_evidence_literature NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion SIO_000772 21147110 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion wasDerivedFrom befree-20140225 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion wasGeneratedBy ECO_0000203 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.